Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Aging Clin Exp Res ; 33(10): 2747-2751, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33604822

RESUMEN

OBJECTIVES: To assess the prevalence of delirium (DEL) among older patients living at home and periodically visited by their General Practitioners (GPs). DESIGN: Observational study. SETTING: In Italy, programmed home visits by the GPs are regularly scheduled for their vulnerable and frail patients who are often on poly-drug regimens and suffering from dementia. PARTICIPANTS: N = 102 patients among those receiving programmed home visits by n = 6 GP based in the Brianza area (Lombardy). MEASUREMENTS: Patients were screened for delirium with the Italian version of the 4AT, with a score ≥ 4 considered as a positive indicator for DEL. The Charlson Comorbidity Index (CCI), the Short Physical Performance Battery (SPPB), the presence of dementia, and benzodiazepine (BZD) use were recorded. RESULTS: DEL+ was detected in almost half of the recruited sample (44.1%), and it was clearly associated with increased comorbidity and decreased motor abilities. Pre-existing dementia was documented in most of DEL+ patients (71.1%), while this was the case for only a minority of DEL- (5.2%, p < 0.00001). Analogously, BZD use was over-represented in the DEL+ group with respect to the DEL- one (73.3% vs. 22.8%, p < 0.00001). CONCLUSIONS: DEL prevalence as detected by GP during programmed home visits is surprisingly high, and related to motor impairment, comorbidities (among which dementia), and BZD use. DEL prompt recognition should be one of the goals of GP-programmed home visits, since this treatable and preventable condition is associated to an elevated burden of frailty and risk of death.


Asunto(s)
Delirio , Fragilidad , Médicos Generales , Delirio/diagnóstico , Delirio/epidemiología , Visita Domiciliaria , Humanos , Encuestas y Cuestionarios
2.
Gynecol Endocrinol ; 30(12): 899-901, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25111756

RESUMEN

The aim of this study is to evaluate the response rate to natural progesterone in non-atypical endometrial hyperplasia and to identify the lowest effective dose. A total of 197 patients of childbearing age with simple or complex hyperplasia were retrospectively identified. The women were treated with a cyclic administration of progesterone at different dosages (100 versus 200 versus 300 mg daily). Endometrial biopsies were performed at 6, 12, 18 months. In comparing progesterone to a regimen of no therapy, a significantly higher remission rate was observed in the progesterone group than in the latter (95 versus 75%, p = 0.05 for simple hyperplasia; 89 versus 35%, p < 0.001 for complex hyperplasia). Out of 60 women with simple hyperplasia, remission was observed in 9/11 (81.8%), 40/41 (97.5%) and 8/8 (100%) patients treated, respectively, with progesterone 100, 200 and 300 mg daily. Out of 72 women with complex hyperplasia, remission was observed in 3/5 (60%), 49/53 (92.4%) and 12/14 (85.7%) patients treated with progesterone 100, 200 and 300 mg daily, respectively. There was no statistically significant difference in the response rate in the two groups, neither with simple nor with complex hyperplasia. In conclusion, progesterone increased the regression rate of both simple and complex hyperplasia.


Asunto(s)
Hiperplasia Endometrial/tratamiento farmacológico , Endometrio/efectos de los fármacos , Progesterona/uso terapéutico , Progestinas/uso terapéutico , Adulto , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Hiperplasia Endometrial/patología , Endometrio/patología , Femenino , Humanos , Persona de Mediana Edad , Progesterona/administración & dosificación , Progestinas/administración & dosificación , Inducción de Remisión/métodos , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
3.
Diagn Ther Endosc ; 2013: 578392, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24371418

RESUMEN

Laparoscopic surgery has been demonstrated as a valid approach in almost all gynaecologic procedures including malignant diseases. Benefits of the minimally invasive approach over traditional open surgery have been well demonstrated in terms of minimal perioperative morbidity and reduced postoperative pain and hospital stay duration, with consequent quick postoperative recovery (Medeiros et al. (2009)). Single-port surgery resurfaced in gynaecology surgery in recent years and renewed interest among other surgeons and within the industry to develop this field (Podolsky et al. (2009)). Patient satisfaction is emerging as an increasingly important measure of quality which represents a complex entity that is dependent on patient demographics, comorbidities, disease, and, to a large extent, patient expectations (Tomlinson and Ko (2006)). It can be broadly thought to refer to all relevant experiences and processes associated with health care delivery (Jackson et al. (2001)). In this study we aim to compare single-port surgery (SPS) with conventional laparoscopy in terms of patient satisfaction using the EORTC IN-PATSAT32 questionnaire. We also evaluate the main surgical outcomes of both minimally invasive approaches.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...